Expression analysis of miRNA and target mRNAs in esophageal cancer

X R Meng1, P Lu2, J Z Mei3

  • 1Oncology Department, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

Insights

This study identified key microRNAs (miRNAs) and their target genes involved in esophageal cancer development using a network approach. hsa-miR-202 was newly linked to esophageal cancer, offering potential therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Esophageal cancer, encompassing esophageal squamous-cell carcinoma (ESCC) and adenocarcinoma (EAC), is a significant global health concern.
  • MicroRNAs (miRNAs) are increasingly recognized as critical regulators in various cancers, including esophageal cancer.
  • Understanding miRNA-mRNA interactions is crucial for elucidating the molecular mechanisms underlying esophageal cancer progression.

Purpose of the Study:

  • To investigate the roles of miRNAs and their related messenger RNAs (mRNAs) in esophageal cancer pathogenesis.
  • To identify differentially expressed miRNAs and their target genes in ESCC and EAC using a network-based approach.
  • To uncover novel molecular players, such as hsa-miR-202, in esophageal cancer biology.

Main Methods:

  • Downloaded miRNA and gene expression data for ESCC and EAC from the Gene Expression Omnibus (GEO) database.
  • Performed differential expression analysis to identify significant miRNAs and genes.
  • Predicted miRNA-target gene interactions and constructed regulatory networks.

Main Results:

  • Identified four differentially expressed miRNAs associated with both EAC and ESCC, including hsa-miR-21 and hsa-miR-202.
  • Reported hsa-miR-202 as a novel miRNA associated with esophageal cancer.
  • Found that target genes of differentially expressed miRNAs are primarily involved in cancer-related pathways, signal transduction, and transcriptional regulation.

Conclusions:

  • The study highlights the potential of specific miRNAs, notably hsa-miR-202, as biomarkers or therapeutic targets in esophageal cancer.
  • Network-based analysis provides insights into the complex regulatory mechanisms involving miRNAs and mRNAs in esophageal cancer.
  • These findings lay the groundwork for future research into targeted therapies for esophageal cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
20.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
7.5K